Werdan K - Search Results

1

E2F2 expression induces proliferation of terminally differentiated cardiomyocytes in vivo.

Ebelt H, Zhang Y, Kampke A, Xu J, Schlitt A, Buerke M, Müller-Werdan U, Werdan K, Braun T. Ebelt H, et al. Among authors: werdan k. Cardiovasc Res. 2008 Nov 1;80(2):219-26. doi: 10.1093/cvr/cvn194. Epub 2008 Jul 15. Cardiovasc Res. 2008. PMID: 18628254

2

Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis.

Ebelt H, Hufnagel N, Neuhaus P, Neuhaus H, Gajawada P, Simm A, Müller-Werdan U, Werdan K, Braun T. Ebelt H, et al. Among authors: werdan k. Circ Res. 2005 Mar 18;96(5):509-17. doi: 10.1161/01.RES.0000159705.17322.57. Epub 2005 Feb 17. Circ Res. 2005. PMID: 15718499

3

Making omelets without breaking eggs: E2F-mediated induction of cardiomyoycte cell proliferation without stimulation of apoptosis.

Ebelt H, Liu Z, Müller-Werdan U, Werdan K, Braun T. Ebelt H, et al. Among authors: werdan k. Cell Cycle. 2006 Nov 1;5(21):2436-9. doi: 10.4161/cc.5.21.3402. Epub 2006 Sep 14. Cell Cycle. 2006. PMID: 17102628

4

Directed expression of dominant-negative p73 enables proliferation of cardiomyocytes in mice.

Ebelt H, Zhang Y, Köhler K, Xu J, Gajawada P, Boettger T, Hollemann T, Müller-Werdan U, Werdan K, Braun T. Ebelt H, et al. Among authors: werdan k. J Mol Cell Cardiol. 2008 Sep;45(3):411-9. doi: 10.1016/j.yjmcc.2008.06.006. Epub 2008 Jun 25. J Mol Cell Cardiol. 2008. PMID: 18634800

5

Endotoxin-activated cultured neonatal rat cardiomyocytes express functional surface-associated interleukin-1alpha.

Westphal E, Li Chen, Pilowski C, Koch S, Ebelt H, Müller-Werdan U, Werdan K, Loppnow H. Westphal E, et al. Among authors: werdan k. J Endotoxin Res. 2007;13(1):25-34. doi: 10.1177/0968051907078609. J Endotoxin Res. 2007. PMID: 17621543

6

Inhibition of p53 after acute myocardial infarction: reduction of apoptosis is counteracted by disturbed scar formation and cardiac rupture.

Zhang Y, Köhler K, Xu J, Lu D, Braun T, Schlitt A, Buerke M, Müller-Werdan U, Werdan K, Ebelt H. Zhang Y, et al. Among authors: werdan k. J Mol Cell Cardiol. 2011 Mar;50(3):471-8. doi: 10.1016/j.yjmcc.2010.11.006. Epub 2010 Nov 11. J Mol Cell Cardiol. 2011. PMID: 21074539

7

Treatment with bone morphogenetic protein 2 limits infarct size after myocardial infarction in mice.

Ebelt H, Hillebrand I, Arlt S, Zhang Y, Kostin S, Neuhaus H, Müller-Werdan U, Schwarz E, Werdan K, Braun T. Ebelt H, et al. Among authors: werdan k. Shock. 2013 Apr;39(4):353-60. doi: 10.1097/SHK.0b013e318289728a. Shock. 2013. PMID: 23376954

8

Apoptosis-modulating interaction of the neuregulin/erbB pathway with anthracyclines in regulating Bcl-xS and Bcl-xL in cardiomyocytes.

Rohrbach S, Muller-Werdan U, Werdan K, Koch S, Gellerich NF, Holtz J. Rohrbach S, et al. Among authors: werdan k. J Mol Cell Cardiol. 2005 Mar;38(3):485-93. doi: 10.1016/j.yjmcc.2004.12.013. J Mol Cell Cardiol. 2005. PMID: 15733908

9

Cellular cardiomyoplasty: improvement of left ventricular function correlates with the release of cardioactive cytokines.

Ebelt H, Jungblut M, Zhang Y, Kubin T, Kostin S, Technau A, Oustanina S, Niebrügge S, Lehmann J, Werdan K, Braun T. Ebelt H, et al. Among authors: werdan k. Stem Cells. 2007 Jan;25(1):236-44. doi: 10.1634/stemcells.2006-0374. Epub 2006 Sep 14. Stem Cells. 2007. PMID: 16973829

10

Decreased beating rate variability of spontaneously contracting cardiomyocytes after co-incubation with endotoxin.

Schmidt H, Saworski J, Werdan K, Müller-Werdan U. Schmidt H, et al. Among authors: werdan k. J Endotoxin Res. 2007;13(6):339-42. doi: 10.1177/0968051907086233. J Endotoxin Res. 2007. PMID: 18182461

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

526 results

Search Page

Filters